Audiologists in Coatesville, PA Accepting Medicare

4 Audiologists found. Showing 1 - 4

Dr. Andrea K Hall, AU.D.,CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1400 Blackhorse Hill Rd, Building 69, Room 125, Coatesville, PA 19320 Phone: 610-384-7711    Fax: 610-380-4327

Ms. Sharon Z. Klavans Audiologist Medicare: Medicare Enrolled Practice Location: 1400 Black Horse Hill Road, 117a Vamc, Coatesville, PA 19320 Phone: 610-384-7711

Mrs. Alicia Christine Gonzalez, M.A., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1400 Blackhorse Hill Rd, Coatesville, PA 19320 Phone: 610-384-7711    Fax: 610-380-4327

Debra Patcherezov, M.ED. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1400 Blackhorse Hill Rd, Coatesville, PA 19320 Phone: 610-384-7711

News Archive

Combination treatment for myocardial infarction shows no added benefit compared to ASA monotherapy

The drug ticagrelor has been approved since February 2016 for adults who had a myocardial infarction a year or more ago and are at a high risk of a new myocardial infarction or stroke.

Polio vaccination launched despite objection from religious group

A partnership between Mali's Ministry of Health and the UN children's fund UNICEF launched a third and final phase of polio immunisation on May 13th, aiming to reach 3.6 million children. Regardless of recent opposition from religious leaders, the three day programme plans to inoculate all children five years and under.

Psychiatric hospitalization rate decreases among adults with schizophrenia treated with INVEGA SUSTENNA: Study

Schizophrenia is a chronic and disabling brain disorder that affects 1 percent of the U.S. population and results in substantial medical and societal costs, in particular from use of health-care resources. It also can have devastating health-related and social effects on people with the disease, their families and caregivers.

Genentech's Lucentis for treatment of macular edema following RVO receives FDA approval

Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved Lucentis® (ranibizumab injection) for the treatment of macular edema following retinal vein occlusion (RVO). The FDA approved this new indication after a six-month Priority Review.

Osteoporosis drug could provide effective pain relief to patients with osteoarthritis

St George's, University of London research has found that a drug normally given to osteoporosis sufferers could provide effective pain relief to patients with knee and hip osteoarthritis.

Read more Medical News

› Verified 8 days ago